Ibrance 125 MG Oral Capsule

RxCUI: 1601390
RxNorm name: Ibrance 125 MG Oral Capsule
Display name: Ibrance 125 MG Oral Capsule
Full name: Ibrance 125 MG Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ibrance	PALBOCICLIB	Pfizer Laboratories Div Pfizer Inc	e0e6412f-50b4-4fd4-9364-62818d121a07	2026-07-02	Warnings, Adverse reactions	Exact identifier rxcui: 1601390

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
e0e6412f-50b4-4fd4-9364-62818d121a07	Ibrance 125 MG Oral Capsule [PSN] · palbociclib 125 MG Oral Capsule [Ibrance] [SBD] · Ibrance 125 MG Oral Capsule [SY]	3	21	These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) capsules, for oral use Initial U.S. Approval: 2015	20260225